Lexeo Therapeutics, Inc. · NASDAQ:LXEO
Balyasny Asset Management L.P. reported a 9.99% stake in Lexeo Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Aug 14, 2025
Balyasny Asset Management L.P. reported a 9.99% stake in Lexeo Therapeutics, Inc., 8,345,651 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 8,345,651
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Balyasny Asset Management L.P. | 9.99% | 8,345,651 |
| BAM GP LLC | 9.99% | 8,345,651 |
| Balyasny Asset Management Holdings LP | 9.99% | 8,345,651 |
| Dames GP LLC | 9.99% | 8,345,651 |
| Dmitry Balyasny | 9.99% | 8,345,651 |
Source
Related
- Lexeo Therapeutics, Inc.
- Balyasny Asset Management L.P.
- Lexeo Therapeutics, Inc. shareholders
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · May 15, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Feb 17, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Nov 14, 2025
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Bhalla Narinder Pal · Sep 28, 2026
- Form 4 · Otero Jose Manuel · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Sep 28, 2026
- Form 4 · Tamayo Louis Edward · Aug 19, 2026